Weight-loss drug to be sold over-the-counter

Weight-loss drug orlistat is set to be available over-the-counter (OTC) later this year.

Photograph: Virgo HEALTH
Photograph: Virgo HEALTH

GlaxoSmithKline (GSK) has received European approval for orlistat 60mg to be available as a pharmacy-only medicine. The drug will be available in the coming months, marketed as Alli.

It will be licensed for treatment of adults with a BMI over 28 who are on a reduced calorie, low-fat diet.

Pharmacy staff will be trained to provide appropriate advice to customers wanting to buy the product, GSK said.

tom.moberly@haymarket.com

Comment below and tell us what you think

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Register

Already registered?

Sign in

Before commenting please read our rules for commenting on articles.

If you see a comment you find offensive, you can flag it as inappropriate. In the top right-hand corner of an individual comment, you will see 'flag as inappropriate'. Clicking this prompts us to review the comment. For further information see our rules for commenting on articles.

comments powered by Disqus